Role of recovery of acetylcholine release in compromised neuromuscular junction function
Neuromuscular Disorders · 2024
DOI: 10.1016/j.nmd.2024.01.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuromuscular Disorders, 2024. Verfasst von Jeppe Blichfeldt Winther und 6 weiteren Autor:innen. Beteiligte Einrichtung: NMD Pharma A/S, Palle Juul-Jensens Blvd. 82, 8200 Aarhus N, Denmark. Hauptthemen laut MEDLINE: Acetylcholine, Activities of Daily Living. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Everyday physical activities, such as walking, are enabled by repeated skeletal muscle contractions and require a well-functioning neuromuscular transmission. In myasthenic disorders, activities of daily living are debilitated by a compromised neuromuscular transmission leading to muscle weakness and fatiguability in patients. To enable physical activity, acetylcholine (ACh) is released repeatedly from the motor nerve, however, the role of the nerve terminals' capacity to sustain ACh release to support repetitive contractions under compromised neuromuscular transmission remains unclear. To explore this, we studied synaptic and contractile function during repeated contractions in healthy rat skeletal muscles under conditions of pharmacological induced compromised neuromuscular transmission. Using recordings of endplate potentials, compound muscle action potential (CMAP) and force production in isolated skeletal muscles and living, anesthetized animals, we found that force and CMAP were markedly reduced by even very light activity performed up to 5 s prior to contraction showing that recovery of ACh release was insufficient to maintain synaptic transmission strength. Our results suggest that the timing of depletion and restoration of ACh release may impact clinical signs of weakness and fatigability in patients with impaired neuromuscular transmission and affect the sensitivity of electromyographic recordings in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NMD Pharma A/S, Palle Juul-Jensens Blvd. 82, 8200 Aarhus N, Denmark.
- Department of Public Health, Aarhus University, Bartholins Allé 2, 8000 Aarhus C, Denmark.
- NMD Pharma A/S, Palle Juul-Jensens Blvd. 82, 8200 Aarhus N, Denmark; Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus C, Denmark. Electronic address: thp@biomed.au.dk.
Zitieren
APA
Winther, J. B., Morgen, J. J., Skov, M., Broch-Lips, M. G., Nielsen, O. B., Overgaard, K., & Pedersen, T. H. (2024). Role of recovery of acetylcholine release in compromised neuromuscular junction function. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2024.01.007
Vancouver
Winther JB, Morgen JJ, Skov M, Broch-Lips MG, Nielsen OB, Overgaard K, et al. Role of recovery of acetylcholine release in compromised neuromuscular junction function. Neuromuscular Disorders. 2024. doi:10.1016/j.nmd.2024.01.007
BibTeX
@article{Winther2024,
author = {Winther, Jeppe Blichfeldt and Morgen, Jeanette Jeppesen and Skov, Martin and Broch-Lips, Martin Gruwier and Nielsen, Ole Bækgaard and Overgaard, Kristian and Pedersen, Thomas Holm},
title = {Role of recovery of acetylcholine release in compromised neuromuscular junction function},
journal = {Neuromuscular Disorders},
year = {2024},
doi = {10.1016/j.nmd.2024.01.007}
}
EUVIMED